Published in Int J Cancer on November 16, 2010
Seasonal variation in diagnosis of invasive cutaneous melanoma in Eastern England and Scotland. Cancer Epidemiol (2015) 1.39
A dermatologist's perspective on vitamin D. Mayo Clin Proc (2012) 0.78
History of Severe Sunburn and Risk of Skin Cancer Among Women and Men in 2 Prospective Cohort Studies. Am J Epidemiol (2016) 0.77
Identifying risk factors using a skin cancer screening program. Cancer Control (2013) 0.75
Role of BMI and hormone therapy in melanoma risk: a case-control study. J Cancer Res Clin Oncol (2017) 0.75
Distinct sets of genetic alterations in melanoma. N Engl J Med (2005) 17.26
Genome-wide association study identifies three loci associated with melanoma risk. Nat Genet (2009) 3.89
Determinants of BRAF mutations in primary melanomas. J Natl Cancer Inst (2003) 3.65
Melanocytic nevi, solar keratoses, and divergent pathways to cutaneous melanoma. J Natl Cancer Inst (2003) 2.70
Sun exposure and melanoma risk at different latitudes: a pooled analysis of 5700 cases and 7216 controls. Int J Epidemiol (2009) 2.32
Classifying melanocytic tumors based on DNA copy number changes. Am J Pathol (2003) 2.05
Reproducibility of skin characteristic measurements and reported sun exposure history. Int J Epidemiol (2002) 1.88
Benign melanocytic naevi as a risk factor for malignant melanoma. Br Med J (Clin Res Ed) (1986) 1.88
Two-stage methods for the analysis of pooled data. Stat Med (2001) 1.78
Number of nevi and early-life ambient UV exposure are associated with BRAF-mutant melanoma. Cancer Epidemiol Biomarkers Prev (2007) 1.76
Malignant melanoma and oral contraceptive use among women in California. Br J Cancer (1977) 1.76
Risk of cutaneous melanoma in relation to the numbers, types and sites of naevi: a case-control study. Br J Cancer (1996) 1.71
Anatomic site, sun exposure, and risk of cutaneous melanoma. J Clin Oncol (2006) 1.65
Number of nevi at a specific anatomical site and its relation to cutaneous malignant melanoma. J Invest Dermatol (2006) 1.52
Epidemiologic evidence for the role of melanocytic nevi as risk markers and direct precursors of cutaneous malignant melanoma. Results of a case control study in melanoma patients and nonmelanoma control subjects. J Am Acad Dermatol (1992) 1.47
Malignant melanoma in England: risks associated with naevi, freckles, social class, hair colour, and sunburn. Int J Epidemiol (1990) 1.44
Cutaneous melanoma in women. I. Exposure to sunlight, ability to tan, and other risk factors related to ultraviolet light. Am J Epidemiol (1995) 1.44
Cutaneous melanoma and sunburns in childhood in a southern European population. Eur J Cancer (1992) 1.33
Case-control study of malignant melanoma in Washington State. II. Diet, alcohol, and obesity. Am J Epidemiol (1994) 1.28
Association of cutaneous malignant melanoma with intermittent exposure to ultraviolet radiation: results of a case-control study in Ontario, Canada. Int J Epidemiol (1999) 1.25
Risk factors for melanoma by body site. Cancer Epidemiol Biomarkers Prev (2005) 1.25
Body site distribution of cutaneous malignant melanoma in relationship to patterns of sun exposure. Int J Cancer (1998) 1.24
Reproducibility of reported measurements of sun exposure in a case-control study. Cancer Epidemiol Biomarkers Prev (1998) 1.22
p53 expression and risk factors for cutaneous melanoma: a case-control study. Int J Cancer (1998) 1.22
The prevalence and determinants of solar keratoses at a subtropical latitude (Queensland, Australia). Br J Dermatol (1998) 1.16
Meta-analysis of risk factors for cutaneous melanoma according to anatomical site and clinico-pathological variant. Eur J Cancer (2009) 1.15
Skin cancer in a subtropical Australian population: incidence and lack of association with occupation. The Nambour Study Group. Am J Epidemiol (1996) 1.15
Reliability and validity of a telephone questionnaire for estimating lifetime personal sun exposure in epidemiologic studies. Cancer Epidemiol Biomarkers Prev (2005) 1.15
Nevus density and melanoma risk in women: a pooled analysis to test the divergent pathway hypothesis. Int J Cancer (2009) 1.13
Hormonal factors and melanoma in women. Med J Aust (1985) 1.12
Reproductive factors, oral contraceptives and risk of malignant melanoma: Western Canada Melanoma Study. Br J Cancer (1985) 1.10
Cutaneous malignant melanoma in women: exogenous sex hormones and reproductive factors. Br J Cancer (1984) 1.05
Solar keratoses: a risk factor for melanoma but negative association with melanocytic naevi. Int J Cancer (1998) 1.03
Pregnancy history and incidence of melanoma in women: a pooled analysis. Cancer Causes Control (2006) 0.99
The Danish case-control study of cutaneous malignant melanoma. III. Hormonal and reproductive factors in women. Int J Cancer (1988) 0.96
Malignant melanoma risk factors by anatomic site: a case-control study and polychotomous logistic regression analysis. Int J Cancer (1996) 0.95
Moles and site-specific risk of nonfamilial cutaneous malignant melanoma in women. J Natl Cancer Inst (1989) 0.94
A pooled analysis of 10 case-control studies of melanoma and oral contraceptive use. Br J Cancer (2002) 0.90
Premature ageing of the skin in a Queensland population. Med J Aust (1991) 0.89
Etiologic factors associated with p53 immunostaining in cutaneousmalignant melanoma. Int J Cancer (2005) 0.88
Cutaneous malignant melanoma in females: the role of hormonal and reproductive factors. Int J Epidemiol (1990) 0.86
Assessment of lifetime cumulative sun exposure using a self-administered questionnaire: reliability of two approaches. Cancer Epidemiol Biomarkers Prev (2009) 0.85
Hormonal and reproductive influences and risk of melanoma in women. Int J Epidemiol (1998) 0.85
Skin characteristics and risk of superficial spreading and nodular melanoma (United States). Cancer Causes Control (2000) 0.84
Overall and site-specific risk of malignant melanoma associated with nevus counts at different body sites: a multicenter case-control study of the German Central Malignant-Melanoma Registry. Int J Cancer (1995) 0.83
Hospital volume and surgical mortality in the United States. N Engl J Med (2002) 25.79
Surgeon volume and operative mortality in the United States. N Engl J Med (2003) 16.97
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature (2011) 13.23
Genome-wide association study identifies eight loci associated with blood pressure. Nat Genet (2009) 12.44
Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995-99: results of the EUROCARE-4 study. Lancet Oncol (2007) 9.57
Cancer survival in five continents: a worldwide population-based study (CONCORD). Lancet Oncol (2008) 7.18
Aging and environmental exposures alter tissue-specific DNA methylation dependent upon CpG island context. PLoS Genet (2009) 7.07
Outpatient gatifloxacin therapy and dysglycemia in older adults. N Engl J Med (2006) 7.01
Mapping cis- and trans-regulatory effects across multiple tissues in twins. Nat Genet (2012) 6.97
Sequence variant on 8q24 confers susceptibility to urinary bladder cancer. Nat Genet (2008) 6.69
Air pollution and lung cancer incidence in 17 European cohorts: prospective analyses from the European Study of Cohorts for Air Pollution Effects (ESCAPE). Lancet Oncol (2013) 6.12
The architecture of gene regulatory variation across multiple human tissues: the MuTHER study. PLoS Genet (2011) 5.95
Fruit, vegetables, and olive oil and risk of coronary heart disease in Italian women: the EPICOR Study. Am J Clin Nutr (2010) 5.50
Factors associated with incomplete colonoscopy: a population-based study. Gastroenterology (2007) 5.30
Educational epidemiology: applying population-based design and analytic approaches to study medical education. JAMA (2004) 5.15
Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer. Nat Genet (2009) 5.14
Sun exposure and mortality from melanoma. J Natl Cancer Inst (2005) 5.08
A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33. Nat Genet (2010) 4.89
A 20-year perspective on the International Fanconi Anemia Registry (IFAR). Blood (2002) 4.59
Circumcision for phimosis and other medical indications in Western Australian boys. Med J Aust (2003) 4.59
Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents. Lancet (2016) 4.49
Routine circumcision practice in Western Australia 1981-1999. ANZ J Surg (2003) 4.36
New common variants affecting susceptibility to basal cell carcinoma. Nat Genet (2009) 4.15
Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium. Lancet Oncol (2006) 4.13
Indoor tanning and risk of melanoma: a case-control study in a highly exposed population. Cancer Epidemiol Biomarkers Prev (2010) 3.95
A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci. Nat Genet (2010) 3.93
Genome-wide association study identifies three loci associated with melanoma risk. Nat Genet (2009) 3.89
Model-based clustering of DNA methylation array data: a recursive-partitioning algorithm for high-dimensional data arising as a mixture of beta distributions. BMC Bioinformatics (2008) 3.89
Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium. Blood (2008) 3.81
Common sequence variants on 20q11.22 confer melanoma susceptibility. Nat Genet (2008) 3.79
Once-only sigmoidoscopy in colorectal cancer screening: follow-up findings of the Italian Randomized Controlled Trial--SCORE. J Natl Cancer Inst (2011) 3.75
Bleeding and perforation after outpatient colonoscopy and their risk factors in usual clinical practice. Gastroenterology (2008) 3.71
Detectable clonal mosaicism and its relationship to aging and cancer. Nat Genet (2012) 3.69
Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised phase III trial. Lancet (2008) 3.62
The population dynamics of cancer: a Darwinian perspective. Int J Epidemiol (2006) 3.59
Quality of life three years after diagnosis of localised prostate cancer: population based cohort study. BMJ (2009) 3.58
Hospital volume, length of stay, and readmission rates in high-risk surgery. Ann Surg (2003) 3.31
The risk of missed diagnosis of acute myocardial infarction associated with emergency department volume. Ann Emerg Med (2006) 3.29
Risk of Guillain-Barré syndrome after seasonal influenza vaccination and influenza health-care encounters: a self-controlled study. Lancet Infect Dis (2013) 3.27
Short- and long-term mortality with localized prostate cancer. Arch Intern Med (2007) 3.23
Lifetime risk of undergoing surgery for pelvic organ prolapse. Obstet Gynecol (2010) 3.14
Survival differences between patients with scalp or neck melanoma and those with melanoma of other sites in the Surveillance, Epidemiology, and End Results (SEER) program. Arch Dermatol (2008) 3.11
Epigenome-wide association study in the European Prospective Investigation into Cancer and Nutrition (EPIC-Turin) identifies novel genetic loci associated with smoking. Hum Mol Genet (2012) 3.07
Risk-treatment mismatch in the pharmacotherapy of heart failure. JAMA (2005) 3.05
A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma. Nature (2011) 2.96
Body size and breast cancer risk: findings from the European Prospective Investigation into Cancer And Nutrition (EPIC). Int J Cancer (2004) 2.96
Hospital volume and late survival after cancer surgery. Ann Surg (2007) 2.93
Fruit and vegetable intake and the risk of stomach and oesophagus adenocarcinoma in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST). Int J Cancer (2006) 2.89
DNA methylation, isocitrate dehydrogenase mutation, and survival in glioma. J Natl Cancer Inst (2010) 2.87
Tumor necrosis factor (TNF) and lymphotoxin-alpha (LTA) polymorphisms and risk of non-Hodgkin lymphoma in the InterLymph Consortium. Am J Epidemiol (2010) 2.86
Serum 25-hydroxyvitamin D3 levels are associated with breslow thickness at presentation and survival from melanoma. J Clin Oncol (2009) 2.85
Association between colonoscopy and colorectal cancer mortality in a US cohort according to site of cancer and colonoscopist specialty. J Clin Oncol (2012) 2.77
Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer. Nat Genet (2009) 2.76
Primary care physician workforce and Medicare beneficiaries' health outcomes. JAMA (2011) 2.73
Genetic variants at 6p21.33 are associated with susceptibility to follicular lymphoma. Nat Genet (2009) 2.73
Geographical variation in the penetrance of CDKN2A mutations for melanoma. J Natl Cancer Inst (2002) 2.70
Genome-wide association study identifies variants at 9p21 and 22q13 associated with development of cutaneous nevi. Nat Genet (2009) 2.65
Meta-analysis of risk factors for cutaneous melanoma: III. Family history, actinic damage and phenotypic factors. Eur J Cancer (2005) 2.63
Hepatocellular carcinoma risk factors and disease burden in a European cohort: a nested case-control study. J Natl Cancer Inst (2011) 2.63
Clinicopathological features of and risk factors for multiple primary melanomas. JAMA (2005) 2.62
Allogeneic cytotoxic T-cell therapy for EBV-positive posttransplantation lymphoproliferative disease: results of a phase 2 multicenter clinical trial. Blood (2007) 2.61
Association between colonoscopy rates and colorectal cancer mortality. Am J Gastroenterol (2010) 2.56
A sequence variant at 4p16.3 confers susceptibility to urinary bladder cancer. Nat Genet (2010) 2.56
Anal intraepithelial neoplasia in the highly active antiretroviral therapy era among HIV-positive men who have sex with men. AIDS (2005) 2.56
Fatty acid composition of plasma phospholipids and risk of prostate cancer in a case-control analysis nested within the European Prospective Investigation into Cancer and Nutrition. Am J Clin Nutr (2008) 2.53
Sun exposure predicts risk of ocular melanoma in Australia. Int J Cancer (2002) 2.50
Rice consumption and urinary arsenic concentrations in U.S. children. Environ Health Perspect (2012) 2.44
Fruit and vegetable intake and mortality from ischaemic heart disease: results from the European Prospective Investigation into Cancer and Nutrition (EPIC)-Heart study. Eur Heart J (2011) 2.42
Human papillomavirus infection and incidence of squamous cell and basal cell carcinomas of the skin. J Natl Cancer Inst (2006) 2.40
A case-control study of smoking and bladder cancer risk: emergent patterns over time. J Natl Cancer Inst (2009) 2.40
Arsenic, organic foods, and brown rice syrup. Environ Health Perspect (2012) 2.37
Genome-wide association study of follicular lymphoma identifies a risk locus at 6p21.32. Nat Genet (2010) 2.37
Epidemiologic evidence on mobile phones and tumor risk: a review. Epidemiology (2009) 2.35
Plasma selenium concentration and prostate cancer risk: results from the European Prospective Investigation into Cancer and Nutrition (EPIC). Am J Clin Nutr (2008) 2.35
Proliferation of prenatal ultrasonography. CMAJ (2010) 2.33
Evaluating medicines: let's use all the evidence. Med J Aust (2007) 2.32
Sun exposure and melanoma risk at different latitudes: a pooled analysis of 5700 cases and 7216 controls. Int J Epidemiol (2009) 2.32
Race and surgical mortality in the United States. Ann Surg (2006) 2.31
The use of the propensity score for estimating treatment effects: administrative versus clinical data. Stat Med (2005) 2.31
Variation in nursing home antipsychotic prescribing rates. Arch Intern Med (2007) 2.30
Genome-wide association study identifies three new melanoma susceptibility loci. Nat Genet (2011) 2.29